Data as of 1:00pm ET
| -0.20 / -2.46%|
The 3 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 8.00. The median estimate represents a +13.49% increase from the last price of 7.93.
The current consensus among 3 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.